Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03452319
Other study ID # FoU VGR: 238651
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 1, 2017
Est. completion date August 30, 2023

Study information

Verified date September 2023
Source Göteborg University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Thoracoabdominal oesophageal resection for cancer is a procedure with high risks for complications, and patients' preoperative status is a crucial factor for outcome. There are only a few studies that evaluate the effect of preoperative intervention, including physical exercises and breathing exercises, after this type of surgery. The aim of the study is therefore to evaluate the effect of a training intervention before resection of the oesophagus. One hundred patients scheduled for oesophagus resection according to Ivor-Lewis from five different hospitals in Sweden will be included. The patients will be randomized to an intervention group or a control group. The training intervention starts directly after preoperative radiotherapy and chemotherapy are given and lasts until three months postoperatively. Intervention includes increased physical activity, strength training and respiratory muscle training. At inclusion and three months after discharge, the patients will undergo tests of physical function and lung function. In addition, they will fill in questionnaires concerning level of physical function, level of physical activity and quality of life. These questionnaires will also be answered one year after surgery.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date August 30, 2023
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patients scheduled to undergo thoracoabdominal oesophagus resection at one of the five included centra Exclusion Criteria: - < two weeks between inclusion and surgery - benign reason for surgery - difficulties in speaking and reading Swedish - other injury or disease limiting the ability to perform the intervention.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Pretraining
Increased physical activity, and daily strength training and breathing exercises.
Usual care
Preoperative information

Locations

Country Name City State
Sweden Sahlgrenska University Hospital Gothenburg

Sponsors (1)

Lead Sponsor Collaborator
Göteborg University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Other Spirometry Vital capacity From inclusion to 3 months postoperatively
Other Respiratory muscle strength Maximal Inspiratory Pressure and maximal expiratory pressure From inclusion to 3 months postoperatively
Other Hand strength Hand strength (Jamar) From inclusion to 3 months postoperatively
Other Leg strength- calf strength Heel rise test From inclusion to 3 months postoperatively
Other Leg strength Chair stands test From inclusion to 3 months postoperatively
Other Rib cage range of motion Chest excursion and Respiratory Movement Measurement Instrument From inclusion to 3 months postoperatively
Other Level of physical activity Scale by Grimby and Frändin From inclusion to 1 year postoperatively (The whole study period)
Other Physical function Disability Rating Index From inclusion to 1 year postoperatively (The whole study period)
Other Postoperative recovery The Postoperative Recovery Profile From surgery to 1 year postoperatively
Other Pain in the ribcage Numeric rating scale, Scale from 0-10 where 0 indicates no pain and 10 worst imaginable pain From inclusion to 1 year postoperatively (The whole study period)
Other Generic Quality of life EORTC 3 modules From inclusion to 1 year postoperatively (The whole study period)
Primary 6 minutes walk test Test of physical capacity From inclusion to 3 months postoperatively
See also
  Status Clinical Trial Phase
Recruiting NCT05685862 - Laser Speckle Contrast Imaging, Surgical Eye & ICG Fluorescence Imaging for Perfusion Assessment of the Gastric Conduit
Recruiting NCT01795768 - Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours Phase 2
Completed NCT05266300 - Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.
Recruiting NCT03978377 - Cardiopulmonary Toxicity of Thoracic Radiotherapy
Active, not recruiting NCT03653052 - Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Durvalumab Phase 2
Recruiting NCT04484636 - PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) N/A
Recruiting NCT05489250 - The PLATON Network
Terminated NCT01795976 - NY-ESO-1 T Cells in OG Cancer Phase 2
Recruiting NCT01843829 - A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer Phase 2
Completed NCT01915693 - ROCS (Radiotherapy After Oesophageal Cancer Stenting) Study Phase 3
Completed NCT02382237 - Comparison of Tumor Glucose Metabolism Before and After Artificial Nutrition N/A
Recruiting NCT04517448 - Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy
Recruiting NCT04232735 - Evidence Based Information Provision to Improve Decision Making After Oesophagogastric Cancer Diagnosis (SOURCE) N/A
Recruiting NCT05642819 - REVOLUTION Surgery (REVOLUTION Surgery)
Recruiting NCT04001478 - Non-invasive Testing for Early oEesophageal Cancer and Dysplasia
Recruiting NCT02741856 - Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation Phase 2/Phase 3
Not yet recruiting NCT05600608 - Augmentation of Volatile Biomarkers of Oesophageal and Gastric Adenocarcinoma From the Tumour Lipidome N/A
Recruiting NCT04481256 - TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY N/A
Recruiting NCT05057013 - HMBD-001 in Advanced HER3 Positive Solid Tumours Phase 1/Phase 2
Not yet recruiting NCT06046846 - Prehabilitation Via a Mobile Application in Oesophago-gastric Cancer N/A